Acorda Therapeutics

$3.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-2.63%) Today

-$0.11 (-2.70%) As of 8:49 PM UTC after-hours

Why Robinhood?

You can buy or sell ACOR and other stocks, options, and ETFs commission-free!

About ACOR

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nalmefene).

CEO

Ronald Cohen

Employees

168

Headquarters

Ardsley, New York

Founded

1995

Market Cap

41.86M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

179.40K

High Today

$4.22

Low Today

$3.91

Open Price

$4.21

Volume

224.39K

52 Week High

$9.84

52 Week Low

$2.53

ACOR Earnings

-$1.06

-$0.71

-$0.35

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 4, After Hours